Results 131 to 140 of about 68,651 (161)

Pancreatic Ductal Adenocarcinoma

2018
Objective: Patients who undergo an R0 resection of their pancreatic ductal adenocarcinoma (PDAC) have an improved survival compared with patients who undergo an R1 resection. It is unclear whether an R1 resection confers a survival benefit over locally advanced (LA) unresectable tumors.
Konstantinidis, Ioannis T, Warshaw, Andrew, Allen, Jill, Blaszkowsky, Lawrence, Castillo, Carlos, Deshpande, Vikram, Hong, Theodore, Kwak, Eunice Lee, Lauwers, Gregory Y., Ryan, David, Wargo, Jennifer Ann, Lillemoe, Keith, Ferrone, Cristina   +12 more
openaire   +4 more sources

Pancreatic Resection for M1 Pancreatic Ductal Adenocarcinoma

Annals of Surgical Oncology, 2006
Improved safety of pancreatic surgery has led to consideration of more aggressive approaches, such as resection for primary pancreatic ductal adenocarcinoma (PDAC) with metastatic disease (M1).A total of 29 patients who underwent pancreatic resection with resection of associated metastatic disease (interaortocaval lymph node dissection, liver resection,
Shailesh V, Shrikhande, Jörg, Kleeff, Carolin, Reiser, Jürgen, Weitz, Ulf, Hinz, Irene, Esposito, Jan, Schmidt, Helmut, Friess, Markus W, Büchler   +8 more
openaire   +2 more sources

Pancreatic Ductal Adenocarcinoma Derived From IPMN and Pancreatic Ductal Adenocarcinoma Concomitant With IPMN

Pancreas, 2011
Pancreatic ductal adenocarcinoma (PDAC) may derive from an intraductal papillary mucinous neoplasm (IPMN) of the pancreas or may develop in the pancreatic duct apart from IPMN. The purpose of this study was to define the clinicopathological features of these 2 entities and compare them with those of ordinary PDAC.Of 765 patients who had surgical ...
Koji, Yamaguchi, Shuichi, Kanemitsu, Takashi, Hatori, Hiroyuki, Maguchi, Yasuhiro, Shimizu, Minoru, Tada, Toshio, Nakagohri, Keiji, Hanada, Manabu, Osanai, Yutaka, Noda, Akihiko, Nakaizumi, Toru, Furukawa, Shinichi, Ban, Bunsei, Nobukawa, Yo, Kato, Masao, Tanaka   +15 more
openaire   +2 more sources

Proteogenomic characterization of pancreatic ductal adenocarcinoma

Cell, 2021
Christopher R Kinsinger, Ana I Robles, David Fenyö   +2 more
exaly  

Surgical Treatment of Pancreatic Ductal Adenocarcinoma

Cancers, 2021
Thilo Hackert, Hackert Thilo
exaly  

Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma: A Physiopathologic and Pharmacologic Review

Cancers, 2022
Khalid O Alfarouk, Tiago Carvalho, Stephan Reshkin   +2 more
exaly  

Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma

Ca-A Cancer Journal for Clinicians, 2020
Dm Simeone, Anirban Maitra, Linda Chu
exaly  

Modifiable Pancreatic Ductal Adenocarcinoma (PDAC) Risk Factors

Journal of Clinical Medicine, 2023
Ewa Małecka-Panas, Małecka-Wojciesko Ewa   +1 more
exaly  

Current and Future Therapies for Pancreatic Ductal Adenocarcinoma

Cancers, 2022
Karen Finn, Brian Moran, Áine Sally
exaly  

Tumor-Associated Macrophages in Pancreatic Ductal Adenocarcinoma: Therapeutic Opportunities and Clinical Challenges

Cancers, 2021
Ashleigh Poh, Matthias Ernst, Ernst Matthias   +2 more
exaly